Hypothermia Does Not Reverse Cellular Responses Caused by Lipopolysaccharide in Neonatal Hypoxic-Ischaemic Brain

Damjan Osredkar1, Hemmen Sabir, Mari Falck

  • 1Department of Physiology, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.

Insights

Bacterial lipopolysaccharide (LPS) sensitisation worsens brain injury in newborn rats after hypoxia-ischaemia. Therapeutic hypothermia (HT) failed to protect against this infection-sensitised injury, indicating a need for new treatment strategies.

Area of Science:

  • Neuroscience
  • Neonatal Research
  • Inflammation Biology

Background:

  • Bacterial lipopolysaccharide (LPS) exacerbates hypoxia-ischaemia (HI) brain injury in newborn rats.
  • Therapeutic hypothermia (HT) is ineffective in this infection-sensitised HI model.
  • Mechanisms underlying therapeutic failure require elucidation.

Purpose of the Study:

  • Investigate cellular mechanisms of LPS-sensitised HI brain injury.
  • Determine the efficacy of therapeutic hypothermia (HT) in this model.
  • Understand the role of apoptosis, astrogliosis, and microglial activation.

Main Methods:

  • Newborn rats received LPS or vehicle, followed by hypoxia-ischaemia.
  • Animals were treated with normothermia (NT) or HT.
  • Neuronal death, apoptosis, astrogliosis, and microglial activation were assessed via Western blot and immunohistochemistry.

Main Results:

  • LPS sensitisation significantly increased apoptotic neuronal loss and caspase-3 activation.
  • Significant astrogliosis and a trend towards increased microglial activation were observed in LPS-sensitised rats.
  • Therapeutic hypothermia (HT) did not mitigate these LPS-induced changes.

Conclusions:

  • LPS-sensitised HI brain injury involves neuronal apoptosis, astrogliosis, and microglial activation.
  • Therapeutic hypothermia (HT) is not neuroprotective in this infection-sensitised neonatal brain injury model.
  • This study highlights the limitations of current therapeutic strategies.
Abstract